Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Diabetologia ; 56(8): 1773-80, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23699989

RESUMO

AIMS/HYPOTHESIS: T helper type (Th) 17 cells have been shown to play important roles in mouse models of several autoimmune diseases that have been classified as Th1 diseases. In the NOD mouse, the relevance of Th1 and Th17 is controversial, because single-cytokine-deficient NOD mice develop diabetes similarly to wild-type NOD mice. METHODS: We studied the impact of IL-17/IFN-γ receptor double deficiency in NOD mice on the development of insulitis/diabetes compared with IL-17 single-deficient mice and wild-type mice by monitoring diabetes-related phenotypes. The lymphocyte phenotypes were determined by flow cytometric analysis. RESULTS: IL-17 single-deficient NOD mice showed delayed onset of diabetes and reduced severity of insulitis, but the cumulative incidence of longstanding diabetes in the IL-17-deficient mice was similar to that in wild-type mice. The IL-17/IFN-γ receptor double-deficient NOD mice showed an apparent decline in longstanding diabetes onset, but not in insulitis compared with that in the IL-17 single-deficient mice. We also found that double-deficient NOD mice had a severe lymphopenic phenotype and preferential increase in regulatory T cells among CD4(+) T cells compared with the IL-17 single-deficient mice and wild-type NOD mice. An adoptive transfer study with CD4(+)CD25(-) T cells from young non-diabetic IL-17 single-deficient NOD mice, but not those from older mice, showed significantly delayed disease onset in immune-deficient hosts compared with the corresponding wild-type mice. CONCLUSIONS/INTERPRETATION: These results indicate that IL-17/Th17 participates in the development of insulitis and that both IL-17 and IFN-γ signalling may synergistically contribute to the development of diabetes in NOD mice.


Assuntos
Diabetes Mellitus Tipo 1/genética , Interferon gama/deficiência , Interleucina-17/deficiência , Transferência Adotiva , Animais , Autoanticorpos/genética , Autoanticorpos/imunologia , Diabetes Mellitus Tipo 1/imunologia , Feminino , Citometria de Fluxo , Interferon gama/genética , Interleucina-17/genética , Masculino , Camundongos , Camundongos Endogâmicos NOD , Camundongos Mutantes , Camundongos SCID
2.
Clin Exp Immunol ; 168(3): 268-73, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22519588

RESUMO

Major histocompatibility complex (MHC) class I-restricted T cell epitopes are generated mainly by the immunoproteasome in antigen-presenting cells. Therefore, inhibition of activity of this proteolytic complex molecule is thought to be a potential treatment for cell-mediated autoimmune diseases. We therefore studied the efficacy of an immunoproteasome inhibitor, ONX 0914 (formerly PR-957), for the treatment of autoimmune thyroid diseases, including cell-mediated Hashimoto's thyroiditis and autoantibody-mediated Graves' hyperthyroidism using mouse models. Our data show that ONX 0914 was effective prophylactically and therapeutically at suppressing the degree of intrathyroidal lymphocyte infiltration and, to a lesser degree, the titres of anti-thyroglobulin autoantibodies in non-obese diabetic (NOD)-H2(h4) mice, an iodine-induced autoimmune thyroiditis model. It also inhibited differentiation of T cells to T helper type 1 (Th1) and Th17 cells, effector T cell subsets critical for development of thyroiditis in this mouse strain. In contrast, its effect on the Graves' model was negligible. Although ONX 0914 exerts its immune-suppressive effect through not only suppression of immune proteasome but also other mechanism(s), such as inhibition of T cell differentiation, the present results suggest that the immunoproteasome is a novel drug target in treatment of Hashimoto's thyroiditis in particular and cell-mediated autoimmune diseases in general.


Assuntos
Inibidores de Cisteína Proteinase/uso terapêutico , Doença de Graves/tratamento farmacológico , Doença de Hashimoto/tratamento farmacológico , Oligopeptídeos/uso terapêutico , Inibidores de Proteassoma , Células Th1/efeitos dos fármacos , Células Th17/efeitos dos fármacos , Animais , Formação de Anticorpos/efeitos dos fármacos , Autoanticorpos/sangue , Células Cultivadas , Inibidores de Cisteína Proteinase/administração & dosagem , Inibidores de Cisteína Proteinase/efeitos adversos , Modelos Animais de Doenças , Doença de Graves/imunologia , Doença de Hashimoto/induzido quimicamente , Doença de Hashimoto/imunologia , Humanos , Imunidade Celular/efeitos dos fármacos , Iodo/administração & dosagem , Camundongos , Camundongos Endogâmicos NOD , Oligopeptídeos/administração & dosagem , Oligopeptídeos/efeitos adversos , Células Th1/imunologia , Células Th1/metabolismo , Células Th1/patologia , Células Th17/imunologia , Células Th17/metabolismo , Células Th17/patologia , Tireoglobulina/imunologia , Glândula Tireoide/efeitos dos fármacos , Glândula Tireoide/patologia
3.
J Gen Microbiol ; 137(7): 1523-8, 1991 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1720165

RESUMO

The genes encoding the 5S ribosomal RNA (rRNA) for Leptonema illini strain 3055 were isolated and sequenced. The 5S RNA molecule encoded was 117 nucleotides long. The genome of strain 3055 contained two genes for 5S rRNA that were located close together. The nucleotide sequences of the Leptonema illini genes exhibited less similarity to the rRNA gene of Leptospira interrogans strain Moulton and also to those of typical eubacterial genes than did the rRNA genes of other leptospires. However, the overall secondary structure of the 5S rRNA encoded exhibited a strong similarity to that of typical eubacterial 5S rRNA. Southern hybridization of the 5S rRNA gene probe with the genomic DNA of strain 965, which is currently classified as Leptospira biflexa, showed the latter to have close similarity to that of strain 3055. The physical map of strain 965 was quite similar to that of strain 3055 and was greatly different from that of any other strains of L. biflexa. In the organization of 5S rRNA genes, strain 965 is sufficiently different from other members of the genus Leptospira to be regarded as a member of the genus Leptonema.


Assuntos
DNA Ribossômico/genética , Genes Bacterianos , Leptospira/genética , Leptospiraceae/genética , RNA Ribossômico 5S/genética , Sequência de Bases , Southern Blotting , Clonagem Molecular , Sondas de DNA/genética , Leptospira/classificação , Leptospiraceae/classificação , Dados de Sequência Molecular , Família Multigênica/genética , RNA Bacteriano/genética , Mapeamento por Restrição
4.
J Bacteriol ; 172(6): 3264-8, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2345145

RESUMO

The gene encoding the 5S rRNA for Leptospira interrogans serovar canicola strain Moulton was isolated and sequenced. The 5S rRNA gene occurs as a single copy within the genome and encodes a 117-nucleotide-long RNA molecule. The 5S rRNA gene is flanked at both the 5' and 3' ends by regions of A + T-rich sequences, and the 5'-flanking region contains a promoter sequence. L. interrogans has a unique and remarkable organization of the 5S rRNA gene. The 5S rRNA molecule exhibits a strong similarity to typical eubacterial 5S rRNA in terms of overall secondary structure, while the primary sequence is conserved to a lesser degree. Restriction analysis of the 5S rRNA gene indicated that the DNA sequence including the 5S rRNA gene is highly conserved in the genomes of parasitic leptospires.


Assuntos
Genes Bacterianos , Leptospira interrogans/genética , RNA Ribossômico 5S/genética , RNA Ribossômico/genética , Sequência de Bases , DNA Bacteriano/análise , Dados de Sequência Molecular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...